Part, Chapter, Paragraph
1 II, 5. 2. 7| in the last year of life. Arch Intern Med 165:1028-34.~
2 II, 5. 2. 7| Borderline Risk Factors. Arch Intern Med. 167:573-579.~
3 II, 5. 5. 3| facts and visions. Eur Arch Psychiatry Clin Neurosci
4 II, 5. 5. 3| schizophrenia: a re-examination. Arch Gen Psychiatry 62(3):247-
5 II, 5. 5. 3| gap worsening over time? Arch Gen Psychiatry 64(10):1123-
6 II, 5. 5. 3| between research and care. Eur Arch Psychiatry Clin Neurosci
7 II, 5. 5. 3| fatigue in multiple sclerosis. Arch Phys Med Rehabil 65:135-
8 II, 5. 5. 3| and prevalence in Ferrara. Arch Neurol 53:793-798.~Gross
9 II, 5. 5. 3| Fatigue in multiple sclerosis. Arch Neurol 45:435-437.~Kurtzke
10 II, 5. 5. 3| Italy, 1967 through 1987. Arch Neurol 48(8):854-857.~Hely
11 II, 5. 8. 7| population-based study. Arch Bronconeumol 40: 72-79.~ ~
12 II, 5. 14. 1| allows adequate dental arch space for the eruption of
13 II, 9. 1. 1| French county, 1980-91. Arch Dis Child 2003;88(2):114-
14 II, 9. 1. 2| of Congenital Anomaly”, Arch Dis Childh, Vol 82, pp 349-
15 II, 9. 1. 2| structural birth defects. Arch Paed Adolesc Med 2007; 161:
16 II, 9. 3. 2| French county, 1980-91. Arch Dis Child 2003;88(2):114-
17 II, 9. 3. 3| risk in Sweden (1989-2003). Arch Sex Behav 34:219-29.~Hessling
18 III, 10. 1. 3| Confounding and interaction. Arch Dermatol 136(12):1544-6.~
19 III, 10. 2. 5| thinness during childhood. Arch Gen Psychiatry 2001;58(1):
20 III, 10. 6. 1| relations and heart disease. Arch Intern Med 167(18):1951-
